Format

Send to

Choose Destination
Exp Hematol. 2000 Sep;28(9):993-1000.

The thin red line: angiogenesis in normal and malignant hematopoiesis.

Author information

1
Division of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy. francesco.bertolini@ieo.it

Abstract

This review describes the current knowledge about cell subsets involved in vasculogenesis (i.e., differentiation of endothelial cells from mesodermal precursors) and angiogenesis (i.e., blood vessel generation from pre-existing vessels), together with recent findings about angiogenesis and antiangiogenic therapies in hematopoietic malignancies such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes.

PMID:
11008011
DOI:
10.1016/s0301-472x(00)00508-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center